高齡化社會所面臨的問題是老年人的相關疾病，其中骨科相關疾病的產業以人工關節為主，目前美國大廠占領了全球人工關節的主要市場，並持續藉由併購增加市場佔有率，增加小廠的競爭壓力。本論文主要探討台灣骨科器材公司邁入國際市場所遭遇的困難與競爭的優勢，藉由PEST，SWOT和Ansoff成長矩陣等研究方法探討個案公司目前主要市場美國與中國大陸可能的機會及其對市場競爭策略。1.美國市場:建議可以東方移民人數多的區域為主要市場，透過提供品質佳但價格較低的產品打入醫院的採購端並藉由提供客製化手術器械加強對目標使用者-臨床醫師的服務。2.大陸市場:建議個案公司必須加強產品的廣度同時往高端與低端市場兩邊同時擴張，及藉由台灣醫師協助對大陸醫師的臨床教育訓練，以爭取更高的市場占有率。最後兩個市場也可考慮與在地的廠商或經銷商合作，藉由合作者在地市場的資源共同開發新市場。

One of the most important issues in aging polulations is aging-related diseases. In orthopedic industies, total joint replacement is the largest marketplace which is dominated by US manufacturers. Though merger and acquisition activites by these US manufacturers, they continue to increase market share while the other small orthopedic companies sustain higher competitive pressure in global marketplace. This research focuses on the growth opportunity and competitive strategy of one Taiwan orthopedic company for its major international markets-US and China. By using PEST, SWOT and Ansoff growth matrix, the possible growth competitive strategies and related markting strategies of the company is investigated. 1. In US market: It is recommended to focus on the area of Asia immigrants, through the provision of good quality but low price products into the hospital's procurement side and by providing customized surgical instruments to strengthen the target users – orthoedic surgeon. 2 in China market: it is recommended to develop more products expansion into both sides of high-end and low-end markets. In order to gain a higher market share, asking surgeons in Taiwan to assist clinical education to China Surgeon. Finally, two markets may also consider cooperation with the local manufacturer or distributor, by using collaborators resources to develop new markets.

1. United Nations Population Division (2011)。
2. 100年國民醫療保健支出統計,衛生福利部統計處 (更新時間：2013/01/17)
3. 身體百科 骨科100問，康健雜誌特刊39號,2013年
4. Harris WH. The first 50 years of total hip arthroplasty: lessons learned. Chip Orthop Relat Res 467(1):28-31, 2009
5. 陳德誠:脊椎融合與非融合手術介紹，國家文官學院 T&D飛訊第112期, 2011/02/01
6. Ricci WH, Gardner M, Jo M, McAndrew C. What’s new in orthopaedic trauma. J Bone Joint Surg Am 94(16):1525-35, 2012
7. 吳清山，林天祐:教育名詞 PEST 分析 教育資料與研究雙月刊 第98期 187-188頁 2011年2月
8. Weihrich, Heinz. The SWOT matrix- a tool for situational analysis. Long range planning, London,Apr 15(2), 54-66, 1982
9. Ansoff, Igor H. Strategies for diversification. Havard Business Review. Sep-Dec, 114, 1975
10. 林坤輝:新創骨科器材公司的競爭策略分析與建議，國立台灣大學管理學院碩士班在職專班商學組碩士論文 2013年
11. 張慈映主編，2013年醫療器材產業年鑑，經濟部技術處，2013年初版
12. Active Implantable Medical Device Directive. EU directive 90/385/EEC,
13. Medical Device Directive (MDD). EU directive 93/42/EEC
14. In Vitro Diagnostic Directive. EU directive 98/79/EC
15. 醫療器材管理辦法, 衛生福利部食品藥物管理署 2006
16. 郭宗富: 品牌與代工經營模式關係之探討－以一家醫療器材中小企業為例，國立中正大學高階主管管理碩士在職專班碩士論文 2013年
17. 行政院經濟建設委員會, 2010 至2060 年台灣人口推計, 行政院主計處, 2010 edition.
18. The orthopaedic industry annual report. ORTHOWORLD® Inc 2013 edition
19. 黃裕斌:骨科醫材市場回顧與未來展望 工業技術研究院 IEK 02/27/2012
20. Knee replacement implants-global pipeline analysis, competitive landscape and market forecasts to 2017. Globaldata July, 2011
21. Hip replacement implants-global pipeline analysis, competitive landscape and market forecasts to 2017. Globaldata June, 2011
22. 醫療器械監督管理條例 國務院令 第650號,2014
23. 謝秀欣、游佩芬、張宜榕、黃彥臻:十二五規畫下中國大陸醫藥與醫療器材市場商機與切入策略 工業技術研究院 IEK 10/31/2011
24. Medical device growth in emerging markets: lessons from other industries. In Vivo: The business & medicine report. June 2012